Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 01-Apr-24 9:30 PM View:  | Igm Biosciences, Inc. (IGMS) | 29-Mar-24 | Grant Duplicate | 1,734 | -- | -- | < 1% 6.15M to 6.15M | |
| 01-Apr-24 9:30 PM View: | Igm Biosciences, Inc. (IGMS) | 28-Mar-24 | Disposition (other) | 12,464 | -- | -- | (< 1%) 6.17M to 6.15M | |
| 01-Apr-24 9:32 PM View: | Shattuck Labs, Inc. (STTK) | 28-Mar-24 | Disposition (other) | 4,425 | -- | -- | (< 1%) 5.62M to 5.62M | |
| 19-Mar-24 9:30 PM View: | Augmedix, Inc. (AUGX) | 15-Mar-24 | Grant Duplicate | 3,125 | -- | -- | < 1% 16.41M to 16.41M | |
| 13-Mar-24 5:17 PM View: | Science 37 Holdings, Inc. (LSAQ) | 12-Mar-24 | Disposition (change in control) | 1,017,200 | $5.75 | $5,848,920.00 | (100%) 1.02M to 0 | |
| 05-Mar-24 9:30 PM View: | Absci Corp (ABSI) | 01-Mar-24 | Private Purchase | 222,222 | $4.50 | $999,999.00 | 3% 8.03M to 8.25M | |
| 01-Mar-24 9:30 PM View: | Igm Biosciences, Inc. (IGMS) | 28-Feb-24 | Conversion | 113,400 | -- | -- | 4% 2.98M to 3.09M | |
| 03-Jan-24 8:46 PM View: | Igm Biosciences, Inc. (IGMS) | 29-Dec-23 | Grant Duplicate | 492 | -- | -- | < 1% 2.98M to 2.98M | |
| 28-Dec-23 9:30 PM View: | Fate Therapeutics Inc (FATE) | 26-Dec-23 | Acquisition (other) | 1,655,370 | $3.72 | $6,157,980.00 | 13% 13.14M to 14.79M | |
| 28-Dec-23 9:30 PM View: | Fate Therapeutics Inc (FATE) | 26-Dec-23 | Disposition (other) | 1,655,370 | $3.72 | $6,157,980.00 | (11%) 14.84M to 13.18M | |
| 28-Dec-23 9:30 PM View: | Fate Therapeutics Inc (FATE) | 26-Dec-23 | Purchase | 44,630 | $3.72 | $166,024.00 | < 1% 14.79M to 14.84M | |
| 19-Dec-23 9:31 PM View: | Augmedix, Inc. (AUGX) | 15-Dec-23 | Grant Duplicate | 1,767 | -- | -- | < 1% 16.4M to 16.41M | |
| 22-Nov-23 4:15 PM View: | Augmedix, Inc. (AUGX) | 20-Nov-23 | Purchase | 750,000 | $4.00 | $3,000,000.00 | 3% 24.35M to 25.1M | |
| 22-Nov-23 4:15 PM View: | Augmedix, Inc. (AUGX) | 20-Nov-23 | Purchase | 750,000 | $4.00 | $3,000,000.00 | 3% 25.1M to 25.85M | |
| 03-Oct-23 10:00 PM View: | Igm Biosciences, Inc. (IGMS) | 29-Sep-23 | Grant Duplicate | 492 | -- | -- | < 1% 2.97M to 2.98M | |
| 21-Sep-23 9:30 PM View: | Rayzebio, Inc. (RYZB) | 19-Sep-23 | Conversion | 1,857,710 | -- | -- | 100% 0 to 1.86M | |
| 05-Sep-23 9:45 PM View: | Augmedix, Inc. (AUGX) | 31-Aug-23 | Grant Duplicate | 2,092 | $4.78 | $9,999.76 | < 1% 15.65M to 15.65M | |
| 17-Jul-23 6:49 PM View: | Augmedix, Inc. (AUGX) | 13-Jul-23 | Grant Duplicate | 21,598 | -- | -- | < 1% 15.63M to 15.65M | |
| 03-Jul-23 9:45 PM View: | Igm Biosciences, Inc. (IGMS) | 30-Jun-23 | Grant Duplicate | 492 | -- | -- | < 1% 8.92M to 8.92M | |
| 03-Jul-23 9:45 PM View: | Igm Biosciences, Inc. (IGMS) | 29-Jun-23 | Acquisition (other) | 54,740 | $9.42 | $515,651.00 | < 1% 8.92M to 8.98M | |
| 03-Jul-23 9:45 PM View: | Igm Biosciences, Inc. (IGMS) | 29-Jun-23 | Disposition (other) | 54,740 | $9.42 | $515,651.00 | (< 1%) 9.06M to 9.0M | |
| 03-Jul-23 9:45 PM View: | Igm Biosciences, Inc. (IGMS) | 29-Jun-23 | Purchase | 80,423 | $9.42 | $757,585.00 | < 1% 8.98M to 9.06M | |
| 03-Jul-23 9:45 PM View: | Igm Biosciences, Inc. (IGMS) | 29-Jun-23 | Sale | 80,423 | $9.42 | $757,585.00 | (< 1%) 9.0M to 8.92M | |
| 15-May-23 9:32 PM View: | Science 37 Holdings, Inc. (LSAQ) | 11-May-23 | Grant Duplicate | 494,853 | $0.25 | $125,000.00 | 2% 19.85M to 20.34M | |
| 04-May-23 10:00 PM View: | Augmedix, Inc. (AUGX) | 02-May-23 | Acquisition (other) | 7,446,150 | $3.00 | $22,338,400.00 | 36% 20.63M to 28.08M | 2% |
| 04-May-23 10:00 PM View: | Augmedix, Inc. (AUGX) | 02-May-23 | Disposition (other) | 5,000,000 | $3.00 | $15,000,000.00 | (18%) 28.08M to 23.08M | (2%) |
| 04-May-23 10:00 PM View: | Augmedix, Inc. (AUGX) | 02-May-23 | Disposition (other) | 7,446,150 | $3.00 | $22,338,400.00 | (32%) 23.08M to 15.63M | (2%) |
| 21-Apr-23 9:55 PM View: | Fate Therapeutics Inc (FATE) | 21-Apr-23 | Purchase | 256,639 | $6.18 | $1,586,030.00 | 2% 12.88M to 13.14M | |
| 21-Apr-23 9:55 PM View: | Fate Therapeutics Inc (FATE) | 20-Apr-23 | Private Purchase | 20,000 | $5.99 | $119,800.00 | < 1% 12.86M to 12.88M | |
| 21-Apr-23 9:30 PM View: | Augmedix, Inc. (AUGX) | 19-Apr-23 | Grant | 1,250,000 | $1.60 | $2,000,000.00 | 9% 14.38M to 15.63M | |
| 17-Apr-23 9:30 PM View: | Fate Therapeutics Inc (FATE) | 14-Apr-23 | Acquisition (other) | 5,492,380 | $5.84 | $32,075,500.00 | 42% 13.14M to 18.63M | |
| 17-Apr-23 9:30 PM View: | Fate Therapeutics Inc (FATE) | 14-Apr-23 | Disposition (other) | 5,492,380 | $5.84 | $32,075,500.00 | (29%) 18.65M to 13.16M | |
| 17-Apr-23 9:30 PM View: | Fate Therapeutics Inc (FATE) | 14-Apr-23 | Purchase | 25,700 | $6.00 | $154,200.00 | < 1% 18.63M to 18.65M | |
| 17-Apr-23 9:30 PM View: | Fate Therapeutics Inc (FATE) | 14-Apr-23 | Sale | 302,339 | $5.84 | $1,765,660.00 | (2%) 13.16M to 12.86M | |
| 17-Apr-23 9:30 PM View: | Fate Therapeutics Inc (FATE) | 13-Apr-23 | Conversion | 167,205 | -- | -- | 1% 12.97M to 13.14M | |
| 04-Apr-23 9:32 PM View: | Igm Biosciences, Inc. (IGMS) | 31-Mar-23 | Grant Duplicate | 492 | -- | -- | < 1% 3.34M to 3.34M | |
| 04-Jan-23 9:33 PM View: | Igm Biosciences, Inc. (IGMS) | 30-Dec-22 | Grant Duplicate | 230 | -- | -- | < 1% 3.34M to 3.34M | |
| 17-Oct-22 9:48 PM View: | Zymeworks Inc. (ZYME) | 13-Oct-22 | Grant | 30,481 | $5.03 | $153,435.00 | < 1% 6.05M to 6.08M | |
| 05-Oct-22 5:01 PM View: | Igm Biosciences, Inc. (IGMS) | 03-Oct-22 | Acquisition (other) | 221,072 | $22.49 | $4,971,910.00 | 7% 3.34M to 3.56M | 11% |
| 05-Oct-22 5:01 PM View: | Igm Biosciences, Inc. (IGMS) | 03-Oct-22 | Disposition (other) | 221,072 | $22.49 | $4,971,910.00 | (6%) 3.56M to 3.34M | (11%) |
| 04-Oct-22 10:01 PM View: | Igm Biosciences, Inc. (IGMS) | 30-Sep-22 | Grant Duplicate | 230 | -- | -- | < 1% 3.34M to 3.34M | |
| 06-Jul-22 5:17 PM View: | Medavail Holdings, Inc. (MDVL) | 01-Jul-22 | Grant | 9,411,760 | $1.06 | $10,000,000.00 | 26% 36.65M to 46.06M | |
| 06-Jul-22 5:17 PM View: | Medavail Holdings, Inc. (MDVL) | 01-Jul-22 | Grant | 7,639,120 | $1.06 | $8,116,560.00 | 17% 46.06M to 53.7M | |
| 05-Jul-22 9:45 PM View: | Igm Biosciences, Inc. (IGMS) | 30-Jun-22 | Grant Duplicate | 230 | -- | -- | < 1% 3.34M to 3.34M | |
| 15-Jun-22 6:02 PM View: | Science 37 Holdings, Inc. (LSAQ) | 13-Jun-22 | Acquisition (other) | 6,472,230 | $3.38 | $21,876,100.00 | 33% 19.85M to 26.32M | |
| 15-Jun-22 6:02 PM View: | Science 37 Holdings, Inc. (LSAQ) | 13-Jun-22 | Disposition (other) | 6,472,230 | $3.38 | $21,876,100.00 | (25%) 26.32M to 19.85M | |
| 13-Jun-22 9:31 PM View: | Fate Therapeutics Inc (FATE) | 09-Jun-22 | Grant Duplicate | 8,650 | -- | -- | < 1% 12.96M to 12.97M | |
| 25-May-22 9:30 PM View: | Science 37 Holdings, Inc. (LSAQ) | 23-May-22 | Grant Duplicate | 40,983 | $3.05 | $124,998.00 | < 1% 19.81M to 19.85M | |
| 06-Apr-22 9:45 PM View: | Medavail Holdings, Inc. (MDVL) | 04-Apr-22 | Grant | 14,117,600 | $1.06 | $15,000,000.00 | 127% 11.08M to 25.19M | |
| 04-Apr-22 9:45 PM View: | Igm Biosciences, Inc. (IGMS) | 31-Mar-22 | Grant Duplicate | 230 | -- | -- | < 1% 3.34M to 3.34M |